Mark S. Leventhal, Director at ProPhase Labs, Inc. (PRPH), bought 35,752 shares at $1.30 ($46K) on 2015-11-25, disclosed to the SEC on 2015-12-08.
Open-market purchase of $46k PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 18,500 | $24K | 51.7% |
| 2 | $1.30 | 17,252 | $22K | 48.3% |
| Total | $1.30 avg | 35,752 | $46K | 100% |
| Filing → |
| PRPH | BUY | 2012-11-30 | $231K | — | Filing → |